AJMC December 19, 2021
During the discussion of disparities in cancer care, one panelist explained that the National Institutes of Health definition of precision medicine is broader than most people realize.
A flashpoint in the discussion of disparities in cancer care concerns data:
If most of the data collected on genetic mutations come from White Europeans, what insights might we have missed? Will approved therapies offer the same level of efficacy in patients of color?
More importantly, what data beyond a person’s genetics are not accounted for in today’s clinical trials that could affect cancer outcomes? And how can artificial intelligence (AI) enable these factors to be part of the care equation?
During the discussion on cancer care disparities at Patient-Centered Oncology Care®, Karen Winkfield,...
Today's Sponsors
Today's Sponsor